Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

BACKGROUND Human cytomegalovirus (HCMV) is the major viral etiology of congenital infection and birth defects. Fetal transmission is high (30%-40%) in primary maternal infection, and symptomatic babies have permanent neurological, hearing, and vision defects. Recurrent infection is infrequently transmitted (2%) and largely asymptomatic. Congenital infection is also associated with intrauterine growth restriction (IUGR). METHODS To investigate possible underlying HCMV infection in cases of idiopathic IUGR, we studied maternal and cord sera and placentas from 19 pregnancies. Anti-HCMV antibodies, hypoxia-related factors, and cmvIL-10 were measured in sera. Placental biopsy specimens were examined for viral DNA, expression of infected cell proteins, and pathology. RESULTS Among 7 IUGR cases, we identified 2 primary and 3 recurrent HCMV infections. Virus replicated in glandular epithelium and lymphatic endothelium in the decidua, cytotrophoblasts, and smooth muscle cells in blood vessels of floating villi and the chorion. Large fibrinoids with avascular villi, edema, and inflammation were significantly increased. Detection of viral proteins in the amniotic epithelium indicated transmission in 2 cases of IUGR with primary infection and 3 asymptomatic recurrent infections. CONCLUSIONS Congenital HCMV infection impairs placental development and functions and should be considered as an underlying cause of IUGR, regardless of virus transmission to the fetus.

[1]  S. Exler,et al.  The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  S. Adler Editorial commentary: Primary maternal cytomegalovirus infection during pregnancy: do we have a treatment option? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Ermani,et al.  Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  G. Parruti,et al.  Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children. , 2012, The Journal of infectious diseases.

[5]  S. Exler,et al.  Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  D. Cabrol,et al.  Functional Screening of TLRs in Human Amniotic Epithelial Cells , 2011, The Journal of Immunology.

[7]  L. Pereira Have we overlooked congenital cytomegalovirus infection as a cause of stillbirth? , 2011, The Journal of infectious diseases.

[8]  N. Graf,et al.  Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. , 2011, The Journal of infectious diseases.

[9]  M. Furione,et al.  Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  D. Zeltser,et al.  Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. , 2010, Thrombosis research.

[11]  S. Shiboski,et al.  Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. , 2010, The American journal of pathology.

[12]  Catherine Klersy,et al.  Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  P. Bernard,et al.  Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  E. Maidji,et al.  Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  E. Patsouris,et al.  Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: Association with pathological findings , 2008, Journal of medical virology.

[16]  D. Ilic,et al.  Isolation of human placental fibroblasts. , 2008, Current protocols in stem cell biology.

[17]  D. Sheppard,et al.  Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. , 2008, The American journal of pathology.

[18]  F. Baldanti,et al.  Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. , 2008, The Journal of general virology.

[19]  Fernando A. B. Colugnati,et al.  Incidence of cytomegalovirus infection among the general population and pregnant women in the United States , 2007, BMC infectious diseases.

[20]  T. Compton,et al.  Human Cytomegalovirus Envelope Glycoproteins B and H Are Necessary for TLR2 Activation in Permissive Cells1 , 2006, The Journal of Immunology.

[21]  B. Sibai,et al.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.

[22]  O. Genbačev,et al.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. , 2006, The American journal of pathology.

[23]  E. Maidji,et al.  Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  W. Britt,et al.  Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[25]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[26]  A. Best,et al.  Passive immunization during pregnancy for congenital cytomegalovirus infection. , 2005, The New England journal of medicine.

[27]  U. Bäder,et al.  Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. , 2005, BJOG : an international journal of obstetrics and gynaecology.

[28]  L. Gottwald,et al.  [Intrauterine growth restriction]. , 2005, Przeglad lekarski.

[29]  G. Mor,et al.  Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. , 2004, American journal of obstetrics and gynecology.

[30]  S. Fisher,et al.  Viral and bacterial pathogens at the maternal-fetal interface. , 2004, The Journal of infectious diseases.

[31]  S. Fisher,et al.  Human Cytomegalovirus Interleukin-10 Downregulates Metalloproteinase Activity and Impairs Endothelial Cell Migration and Placental Cytotrophoblast Invasiveness In Vitro , 2004, Journal of Virology.

[32]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[33]  S. Fisher,et al.  Human Cytomegalovirus Transmission from the Uterus tothe Placenta Correlates with the Presence of Pathogenic Bacteria andMaternalImmunity , 2003, Journal of Virology.

[34]  K. Fowler,et al.  Maternal immunity and prevention of congenital cytomegalovirus infection. , 2003, JAMA.

[35]  N. Uldbjerg,et al.  Antibacterial properties of human amnion and chorion in vitro. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[36]  O. Genbačev,et al.  Human Cytomegalovirus Infection of Placental Cytotrophoblasts In Vitro and In Utero: Implications for Transmission and Pathogenesis , 2000, Journal of Virology.

[37]  F. Baldanti,et al.  Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[38]  P. Goubau,et al.  Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[39]  M. Scharff MONOCLONAL ANTIBODY PRODUCTION , 1999 .

[40]  Uwe Marx,et al.  Monoclonal Antibody Production , 1997 .

[41]  R. Redline,et al.  Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. , 1995, Human pathology.

[42]  M. Debakey,et al.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis , 1994, Journal of medical virology.

[43]  P. Paz,et al.  Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. , 1993, Virology.

[44]  R. K. Miller,et al.  Cytomegalovirus infection of the human placenta: an immunocytochemical study. , 1992, Human pathology.

[45]  F. P. Hadlock,et al.  In utero analysis of fetal growth: a sonographic weight standard. , 1991, Radiology.

[46]  M. Daemen,et al.  Cytomegalovirus nucleic acid distribution within the human vascular tree. , 1991, The American journal of pathology.

[47]  A. G. García,et al.  Placental morphology in cytomegalovirus infection. , 1989, Placenta.

[48]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[49]  G. Wood,et al.  Human amnion as a model for IgG transport. , 1987, American journal of reproductive immunology and microbiology : AJRIM.

[50]  W. Britt,et al.  Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome , 1987 .

[51]  J. Trentin,et al.  Replication of cytomegalovirus in human arterial smooth muscle cells , 1985, Journal of virology.

[52]  M. Debakey,et al.  CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.

[53]  D. Mckie Editorial: Where the axe is falling. , 1974, Lancet.